1
00:00:00,000 --> 00:00:04,667
How does a three-amino-acid peptide get inside a gut cell?

2
00:00:04,667 --> 00:00:08,917
That question sits at the centre of KPV research.

3
00:00:08,917 --> 00:00:15,167
In laboratory-grown intestinal and immune cells, researchers found that a transporter called PepT1 could

4
00:00:15,167 --> 00:00:18,667
carry KPV inside. Inflammatory signalling then changed.

5
00:00:18,667 --> 00:00:23,750
The same research reported reduced inflammation in mouse models of colitis.

6
00:00:23,750 --> 00:00:30,000
Human-derived cells and mice are useful steps, but neither establishes treatment benefits in patients.

7
00:00:30,000 --> 00:00:35,458
FDA reports a lack of human exposure information for KPV drug products.

8
00:00:35,458 --> 00:00:41,333
Delivery, safety and meaningful clinical outcomes remain questions to answer before making gut-healing

9
00:00:41,333 --> 00:00:44,833
claims.